ILS has recruited trained scientists to develop technology platforms in the areas of drug discovery, clinical proteomics, gene therapy, nanotechnology, computational biology, structural biology, medical genetics and tumor biology. These groups are working on cutting-edge, multi-disciplinary, collaborative research projects and making efforts to lift basic research to the next level wherein findings are being put to use for practical applications that improve human health and well-being. The institute is thus contributing to the broader theme ‘from bench to bedside’. The collaborative projects with hospitals and medical institutions give an upper hand for ILS in its effort to stay focused on translational research.